JPMorgan: Start Accumulating The Preferred For Income, Hold The Common At 3.2x Book

JPMorgan delivered near-peak operating results, with Q2 ROTCE of approximately 23% and record Markets and Investment Banking revenue. However, its common stock trades at historically elevated valuations of roughly 3.2x tangible book value and 14.8x forward earnings, supporting a Hold view amid multiple-compression risk. JPM preferred shares, including JPM.PR.M, JPM.PR.K, JPM.PR.J and JPM.PR.L, yield about 6.4% and trade at discounts, though interest-rate risk limits near-term upside.

Analysis

JPM’s core risk is not an earnings air pocket but a valuation de-rating if peak capital-markets activity normalizes while net interest income remains pressured by deposit repricing and eventual easing. At a premium tangible-book multiple, the stock requires sustained ROTCE materially above its cost of equity; even unchanged earnings can produce mid-single-digit downside if the multiple migrates toward the large-bank premium range. The immediate read-through is more negative for money-center peers with weaker fee franchises—BAC, C and WFC—because JPM’s results raise the competitive bar for investment-banking share and technology spending rather than validating a sector-wide earnings upgrade.

Over the next 1-3 months, the key catalyst is whether fee-income strength broadens into advisory and underwriting backlog conversion rather than remaining trading-led. A resilient capital-markets cycle supports GS and MS more directly on operating leverage, while JPM’s diversification makes it the lower-beta expression. Conversely, a sharp decline in rates could support unrealized securities marks across banks but compress reinvestment yields and expose the market’s assumption that JPM can retain current returns without a favorable rate backdrop.

The preferreds are an income instrument, not a clean equity substitute: their upside is capped and their price sensitivity is dominated by long-end Treasury yields, call expectations, and bank-credit spreads. The apparent yield advantage is therefore only attractive if the investor expects stable-to-lower long rates without a material widening in financial credit spreads. Consensus may be too focused on JPM’s headline premium and insufficiently focused on the durability of its scale advantage; however, that is a reason to own it against weaker banks, not necessarily to add outright at a cycle-high valuation.

Key Decisions for Investors

• Maintain JPM as a core-quality holding but do not chase common stock at current valuation; add only on a 10-15% pullback or if forward ROTCE guidance/consensus remains above 20%. Falsifier: sustained fee-income acceleration coupled with upward full-year NII guidance, which would justify the premium multiple.
• Express relative quality via long JPM / short KBE or short an equal-weight basket of BAC and C over 3-6 months. JPM’s franchise should retain share if markets activity remains healthy, while lower-return peers have less room to absorb deposit-cost and technology-investment pressure.
• For a capital-markets momentum view, prefer long GS or MS versus JPM over the next earnings cycle; these have greater earnings torque if underwriting and advisory convert. Exit if investment-banking fee guidance or deal-announcement trends weaken materially.
• Treat JPM.PR.M, JPM.PR.K, JPM.PR.J and JPM.PR.L as watch-list yield exposure rather than a tactical buy until 10-year Treasury yields stabilize or decline and bank CDS spreads remain contained. Avoid using preferreds to express a bullish JPM earnings thesis; they will not participate meaningfully in equity upside.
• Monitor JPM’s next guidance for NII ex-Markets, deposit beta, compensation ratio, and capital-markets fee backlog. A downward revision in any two of these metrics would increase the probability of multiple compression and support reducing common exposure.